The new entity will leverage TriNetX's LIVE platform, which encompasses a network of 200 million patient records.

TriNetX, a global leader in real-world data (RWD) and real-world evidence (RWE) solutions, has partnered with Fujitsu, a ...

We aim to determine rates of post-stroke BP control from a broader population within the first year of stroke from multiple cohorts of patients, including from a large US fee-for-service health system ...

The VisionCyte platform leverages high resolution morphological profiling, high-throughput capabilities, and advanced AI analysis to uncover novel biomarkers and facilitate the discovery of new and ...

Aflibercept (AFL) vs. ramucirumab (RAM) -based therapy in patients with advanced colorectal cancer: Efficacy comparison using real-world data evidence from TriNetX platform. Real-world survival ...

The effect of renin-angiotensin system inhibitors on patients with pancreatic cancer receiving systemic treatment: A retrospective cohort study from TriNetX US collaborative networks. This is an ASCO ...

However, the relationship between VDD and the risk of depression in this population remains unclear. Methods: Using the TriNetX network database (2010–2019), we conducted a propensity score-matched ...

Using data from the TriNetX database — a cohort of more than 65 million adult patients across 64 health care organizations — Dulal and colleagues analyze trends over time to assess changes in ...

Subarachnoid hemorrhage (SAH), an accumulation of blood between the pia and arachnoid mater, is most often caused by non‐traumatic rupture of a cerebral aneurysm. Common risk factors that contribute ...

CAMBRIDGE, Mass., Jan. 9, 2025 /PRNewswire/ -- TriNetX, the largest global source of real-world data, today announced that Gadi Lachman, the Company's Founder, President and CEO, will step down from ...